Cargando…

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Cheng, Jiqiu, Demeulemeester, Jonas, Wedge, David C., Vollan, Hans Kristian M., Pitt, Jason J., Russnes, Hege G., Pandey, Bina P., Nilsen, Gro, Nord, Silje, Bignell, Graham R., White, Kevin P., Børresen-Dale, Anne-Lise, Campbell, Peter J., Kristensen, Vessela N., Stratton, Michael R., Lingjærde, Ole Christian, Moreau, Yves, Van Loo, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297227/ https://www.ncbi.nlm.nih.gov/pubmed/30559362 http://dx.doi.org/10.1038/s41467-018-07842-2

Ejemplares similares

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Cheng, Jiqiu, et al.
Publicado: (2017)

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Cheng, Jiqiu, et al.
Publicado: (2019)

Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN
por: Borge, Kaja S., et al.
Publicado: (2015)

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
por: Zhao, Xi, et al.
Publicado: (2014)

DNA copy number motifs are strong and independent predictors of survival in breast cancer
por: Pladsen, Arne V., et al.
Publicado: (2020)

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
por: Höglander, Elen Kristine, et al.
Publicado: (2018)

The multitude of molecular analyses in cancer: the opening of Pandora’s box
por: Russnes, Hege G, et al.
Publicado: (2014)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
por: Nilsen, Gro, et al.
Publicado: (2012)

Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
por: Demeulemeester, Jonas, et al.
Publicado: (2016)

Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2021)

A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2016)

Correction to: A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2018)

PathTracer: High-sensitivity detection of differential pathway activity in tumours
por: Nygård, Ståle, et al.
Publicado: (2019)

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
por: Solvang, Hiroko K, et al.
Publicado: (2011)

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015)

Allele-specific disparity in breast cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2011)

The pathology of inherited breast tumours
por: Stratton, M
Publicado: (2000)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

Next-Generation Sequencing of Disseminated Tumor Cells
por: Møller, Elen K., et al.
Publicado: (2013)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Drivers underpinning the malignant transformation of giant cell tumour of bone
por: Fittall, Matthew W, et al.
Publicado: (2020)

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2015)

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007)

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
por: Molloy, Timothy J, et al.
Publicado: (2011)

Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4
por: Prasmickaite, Lina, et al.
Publicado: (2018)

Molecular Profiles of Pre- and Postoperative Breast Cancer Tumours Reveal Differentially Expressed Genes
por: Riis, Margit L. H., et al.
Publicado: (2012)

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
por: Castro-Mondragon, Jaime A, et al.
Publicado: (2022)

Promises and challenges of adoptive T-cell therapies for solid tumours
por: Morotti, Matteo, et al.
Publicado: (2021)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
por: Sternemalm, J, et al.
Publicado: (2014)

Multilocus analysis of SNP and metabolic data within a given pathway
por: Kristensen, Vessela N, et al.
Publicado: (2006)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

Integrated study of copy number states and genotype calls using high-density SNP arrays
por: Sun, Wei, et al.
Publicado: (2009)

Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
por: Edvardsen, Hege, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3jdimuo46troqqfqmh47nu43dp